Helicobacter pylori
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
PATHOGENS
- Helicobacter pylori: attaches to gastric cells inducing inflammation and cytokine production.
- Antimicrobial effects:
- H. pylori is intrinsically resistant to sulfonamides, trimethoprim and vancomycin.
- Metronidazole resistance estimated 22-39%, 37% commonly cited in U.S. populations.
- Clarithromycin resistance ~11-12%, in some studies up to 24%.
- Amoxicillin or tetracycline resistance remains less common.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
PATHOGENS
- Helicobacter pylori: attaches to gastric cells inducing inflammation and cytokine production.
- Antimicrobial effects:
- H. pylori is intrinsically resistant to sulfonamides, trimethoprim and vancomycin.
- Metronidazole resistance estimated 22-39%, 37% commonly cited in U.S. populations.
- Clarithromycin resistance ~11-12%, in some studies up to 24%.
- Amoxicillin or tetracycline resistance remains less common.
There's more to see -- the rest of this entry is available only to subscribers.